Skip to main content
. Author manuscript; available in PMC: 2009 Aug 18.
Published in final edited form as: Vaccine. 2008 Jun 17;26(35):4617–4623. doi: 10.1016/j.vaccine.2008.05.084

Figure 2. Blood and mucosal CTL responses to HIV-1 and vaccinia components of the TBC-3B vaccine.

Figure 2

The CTL response (by IFN-γ ELISpot) against HIV-1 (panels A/B) and vaccinia (panels C/D) in blood (panels A/C) and gut mucosa (panels B/D) compartments are plotted over time (the value plotted at week 0 is the mean of two baseline pre-vaccination evaluations). The solid and open symbols indicate participants who received deltoid and inguinal immunization respectively; arrowheads indicate the timing of vaccinations. The lines and error bars represent the means and SE across all participants.